[PERSON]
Michelino De Laurentiis
Featured in 2 tracked stories · first seen
Situations
Ribociclib Natalee study breast cancer results
2 clusters · 8 sources · last updated
Latest: Ribociclib reduces early breast cancer death risk by 20% in 6-year study
Long-term data from the Phase III Natalee study indicates that ribociclib (Kisqali), when combined with hormone therapy, reduces the risk of death by approximately 19% to 20% in patients with early-stage, HR-positive, HE
Also covered in
-
Oncologist Michelino De Laurentiis says chemotherapy patients can safely vacation
[HEALTH] · 3 sources ·